Patents by Inventor ENVIVO PHARMACEUTICALS, INC.

ENVIVO PHARMACEUTICALS, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TETRASUBSTITUTED BENZENES
    Publication number: 20130165486
    Abstract: Tetrasubstituted benzenes that act as modulators of gamma secretase and their use in the treatment of one or more symptoms of treating neurodegenerative disorders, e.g., Alzheimer's disease, are described.
    Type: Application
    Filed: February 1, 2013
    Publication date: June 27, 2013
    Applicant: ENVIVO PHARMACEUTICALS, INC.
    Inventor: ENVIVO PHARMACEUTICALS, INC.
  • Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
    Publication number: 20130137717
    Abstract: (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide has been found to have procognitive effects in humans at unexpectedly low doses. Thus, (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof can be used at unexpectedly low doses to improve cognition.
    Type: Application
    Filed: November 12, 2012
    Publication date: May 30, 2013
    Applicant: ENVIVO PHARMACEUTICALS, INC.
    Inventor: ENVIVO PHARMACEUTICALS, INC.